Oncolytics Biotech Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
4.49
|
|
Average Rating
|
4.20
|
|
# Strong Buys
|
1
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.11
|
-0.08
|
0.03
|
27.27%
|
|
2022-06-30
|
-0.11
|
-0.09
|
0.02
|
18.18%
|
|
2022-03-31
|
-0.15
|
-0.12
|
0.03
|
20.00%
|
|
2021-12-31
|
-0.13
|
-0.14
|
-0.01
|
-7.69%
|
|
2021-09-30
|
-0.14
|
-0.09
|
0.05
|
35.71%
|
|
2021-06-30
|
-0.12
|
-0.13
|
-0.01
|
-8.33%
|
|
2021-03-31
|
-0.17
|
-0.13
|
0.04
|
23.53%
|
|
2020-12-31
|
-0.15
|
-0.22
|
-0.07
|
-46.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.29
|
|
2021-12-31
|
-0.49
|
|
2020-12-31
|
-0.54
|
|
2019-12-31
|
-0.93
|
|
2018-12-31
|
-1.03
|
|
2017-12-31
|
-1.13
|
|
2016-12-31
|
-0.96
|
|
2015-12-31
|
-0.12
|
|
2014-12-31
|
-1.13
|
|
2013-12-31
|
-2.65
|
|
2012-12-31
|
-4.46
|
|
2011-12-31
|
-3.79
|
|
2010-12-31
|
-3.12
|
|
2009-12-31
|
-2.93
|
|
2008-12-31
|
-3.80
|
|
2007-12-31
|
-3.33
|
|
2006-12-31
|
-3.30
|
|
2005-12-31
|
-3.08
|
|
2004-12-31
|
-3.76
|
|
2003-12-31
|
-2.84
|